27.01.2017 09:30

€16m cash boost for adverse drug reaction research

A new €16m European research project has been launched which aims to improve the understanding of adverse drug reactions and the approach of systems modelling approaches to drug safety. Adverse drug reactions (ADRs) are the unwanted side effects of medication. They can contribute significantly to patient morbidity, mortality and hospitalisation costs. Funded by the Innovative Medicines Initiative 2 Joint Undertaking (IMI 2 Joint Undertaking) the five-year project, called Translational Quantitative Systems Toxicology (TransQST), aims to develop novel computational approaches using the best available data from the public and private domains to address the problems of drug safety. The group of Prof. Julio Saez-Rodriguez at the Joint Research Center for Computational Medicine will contribute with approaches to model intracellular networks.

Press release